|Chemical Formula:||C36H54O4, C12H23N|
|Format:||White to off-white crystalline solid|
|Purity:||>95 % determined by HPLC; <2 % Hyperforin by HPLC|
|Solubility:||Soluble in methanol and ethanol|
|Stability:||Studies have not been conducted on Adhyperforin DCHA. It should be similar to Hyperforin DCHA, which shows no decomposition after 60 days at 43C.|
|Storage:||5C, avoid exposure to oxygen and direct sunlight|
Adhyperforin DCHA HPLC Chromatogram.
Purification Notes: Initial silica chromatography separates oils and polar components from hyperforin and adhyperforin. Then C18 chromatography is used to separate hyperforin and adhyperforin. Hyperforin is in greater quantity and in the reversed phase system, hyperforin leads the adhyperforin. This means that the initial fractions will be hyperforin devoid of adhyperforin, and the later fractions will be adhyperforin contaminated with low levels of hyperforin. Adhyperforin is then purified and stabilized by the formation of the dicyclohexylammonium salt.
- Beerhues L. (2006). Hyperforin. Phytochemistry. 67, 2201-2207.
- Cantoni L, Rozio M, Mangolini A, Hauri L and Caccia S. (2003). Hyperforin Contributes to the Hepatic CYP3A-Inducing Effect of Hypericum perforatum Extract in the Mouse. Toxicological Sciences. 75, 25-30.
- Cervo L, Rozio M, Ekalle-Soppo C, Guiso G, Morazzoni P and Caccia S. (2002). Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts. Psychopharmacology. 164, 423-428.
- Linde K, Ramirez G, Murlow C, Pauls A, Weidenhammer W and Melchart D. (1996). St John's wort for depressionan overview and meta-analysis of randomized clinical trials. BMJ. Aug 3; 313(7052):253-258.
- Woelk H. (2000). Comparison of St John's wort and imipramine for treating depression: randomized controlled trials. BMJ. 321, 536-539.
If you publish research with this product, please let us know so we can cite your paper.